Scilex Holding Company
Scilex Holding Company (SCLX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SCLX · as of Jun 9, 2026
Key Statistics
Explore Scilex Holding Company Data
sclx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
sclx competitorsSCLX
ABOS
AGEN
ALEC
CTOR
INOStock Performance
Full HistoryAbout Scilex Holding Company
Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its prim…
what is scilex holding company · sclx stock overview · scilex holding company company profile · who is scilex holding company ceo · sclx NASDAQ · scilex holding company headquarters · scilex holding company business segments
About Stock Overview & Key Data
Scilex Holding Company (SCLX) is a Healthcare company in the Drug Manufacturers - General industry, listed on NASDAQ since Mar 5, 2021. As of the latest trading session, SCLX stock price is $6.91, with a market capitalization of $58.7M. The stock has returned +11.81% over the past 12 months and -43.36% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Scilex Holding Company stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Scilex Holding Company reported revenue of $30.3M and net income of -$358.7M. For detailed data — including Scilex Holding Company revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Scilex Holding Company (SCLX) stock price is $6.91. The stock is traded on NASDAQ under the ticker symbol SCLX. The 52-week range is $4.20 – $34.27.